Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-13-000369
Filing Date
2013-02-01
Accepted
2013-01-31 21:43:10
Documents
11
Period of Report
2012-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A f20fa_013113.htm 20-F/A 65257
2 EXHIBIT 12.1 exh_121.htm EX-12.1 5220
3 EXHIBIT 12.2 exh_122.htm EX-12.2 5298
4 EXHIBIT 15.1 exh_151.htm EX-15.1 5099
11 deloitte.jpg GRAPHIC 27002
  Complete submission text file 0001171843-13-000369.txt   9301545

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ipci-20121130.xml EX-101.INS 2202725
6 XBRL TAXONOMY EXTENSION SCHEMA ipci-20121130.xsd EX-101.SCH 75059
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipci-20121130_cal.xml EX-101.CAL 39701
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipci-20121130_def.xml EX-101.DEF 381606
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipci-20121130_lab.xml EX-101.LAB 492710
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipci-20121130_pre.xml EX-101.PRE 383979
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 20-F/A | Act: 34 | File No.: 000-53805 | Film No.: 13564507
SIC: 2834 Pharmaceutical Preparations